Genpact Limited G
33.10
(0.27)
(0.81%)
as of 25 Sep
- Market cap
- $5.6B
- P/E
- 9.7×
Follow G
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
13.26 | 14.71 | 11.29 | 8.09 |
P/S ratio |
1.45 | 1.60 | 1.23 | 0.89 | |
P/FCF ratio |
11.27 | 11.23 | 9.74 | 8.42 | |
P/Operating CF |
23.58 | 28.37 | (269.55) | 64.18 | |
P/B ratio |
2.86 | 3.19 | 2.56 | 1.78 | |
Price to Tangible BV |
10.55 | 11.60 | 9.95 | 6.10 | |
EV/Sales |
1.54 | 1.67 | 1.35 | 1.01 | |
EV/EBITDA |
9.20 | 10.00 | 8.06 | 6.07 | |
EV/Operating CF |
10.60 | 10.42 | 9.28 | 8.25 | |
EV/FCF |
11.99 | 11.70 | 10.67 | 9.62 | |
Quick Ratio |
1.38 | 1.53 | 1.53 | 1.77 | |
Current Ratio |
1.51 | 1.66 | 1.69 | 2.00 | |
Net Debt/EBITDA |
2.12 | 1.52 | 2.76 | 3.10 | |
Debt/Assets |
22.43% | 26.39% | 27.35% | 21.80% | |
Debt/Equity |
0.47 | 0.61 | 0.62 | 0.45 | |
Asset Turnover |
0.94 | 0.94 | 0.98 | 0.98 | |
Operating CF/Net income |
2.11 | 2.00 | (0.16) | 0.50 | |
Capex/Depreciation |
(0.73) | (0.82) | (1.45) | (0.89) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.30% | 21.01% | 20.86% | 21.89% | |
Intangible Assets out of Total Assets |
0.35 | 0.32 | 0.33 | 0.34 | |
Share Based Compensation of Revenue |
1.72% | 1.94% | 1.72% | 1.96% | |
Graham Net Nets |
(0.08) | (0.08) | (0.12) | (0.14) | |
Graham Number |
32.28 | 32.39 | 32.85 | 34.33 | |
Earnings Yield |
7.54% | 6.80% | 8.86% | 12.36% | |
Free Cash Flow Yield |
8.87% | 8.90% | 10.27% | 11.88% | |
Revenue per Share |
7.44 | 7.59 | 7.61 | 7.95 | |
Operating CF per Share |
1.78 | 1.65 | (0.14) | 0.43 | |
Capex per Share |
(0.11) | (0.13) | (0.18) | (0.11) | |
Free Cash Flow per Share |
1.66 | 1.52 | (0.32) | 0.32 | |
Cash per Share |
4.27 | 6.92 | 5.45 | 3.06 | |
Shareholders Equity per Share |
14.66 | 14.66 | 14.53 | 15.41 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.66 | 14.66 | 14.53 | 15.41 | |
Free Cash Flow |
288.91 | 264.84 | (54.98) | 53.66 | |
Working Capital |
750.85 | 1,053.89 | 979.00 | 1,082.99 | |
Capital Expenditures |
(19.45) | (21.86) | (31.45) | (18.78) | |
Net Current Asset Value |
(607.13) | (637.50) | (736.79) | (637.54) | |
EV/EBIT |
10.38 | 11.29 | 9.09 | 6.82 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
11.29% | 10.85% | 11.42% | 10.85% | |
Price to Operating Income |
9.76 | 10.84 | 8.29 | 5.97 | |
| Other line items | |||||
Average Receivables |
1,247.52 | 1,219.58 | 1,226.01 | 1,334.73 | |
Average Payables |
26.65 | 32.00 | 31.76 | 30.02 | |
Average Assets |
5,344.91 | 5,415.21 | 5,256.10 | 5,360.39 | |
Average Common Equity |
2,469.61 | 2,469.51 | 2,464.13 | 2,595.70 |
Columns are period end dates